(Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt structure
|
Common Name | (Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 201995-58-6 | Molecular Weight | 3171.70 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C142H240N44O38 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of (Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt[K15,R16,L27]VIP(1-7)/GRF(8-27), a VIP1 selective agonist, exhibits IC50 values of binding of 2 nM, 1 nM, 30,000 nM for the human VIP1, rat VIP1, rat VIP2 receptors, respectively[1]. VIP: VASOACTIVE Intestinal Polypeptide. |
Name | (Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt |
---|---|
Synonym | More Synonyms |
Description | [K15,R16,L27]VIP(1-7)/GRF(8-27), a VIP1 selective agonist, exhibits IC50 values of binding of 2 nM, 1 nM, 30,000 nM for the human VIP1, rat VIP1, rat VIP2 receptors, respectively[1]. VIP: VASOACTIVE Intestinal Polypeptide. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C142H240N44O38 |
Molecular Weight | 3171.70 |
Exact Mass | 3169.820068 |
LogP | -3.86 |
Index of Refraction | 1.648 |
L-Histidyl-L-seryl-L-α-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-seryl-L-alanyl-L-arginyl- L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucinamide |
L-Leucinamide, L-histidyl-L-seryl-L-α-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-seryl-L-al anyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl- |